SCHEMBL15436573

SCHEMBL15436573

N#Cc1c[nH]c(C(=O)Nc2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.45
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
TP53 P04637 1/20 0.43
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALOX15 P16050 1/20 0.41
CDK2 P24941 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 3/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ATR Q13535 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15436508 0.86 KMT2A (0.46) RAB9ASMN1; SMN2NPC1TP53LMNA
SCHEMBL28063183 0.78 POLB (0.59) POLBRAB9ASMN1; SMN2NPC1TP53
SCHEMBL20094688 0.77 POLB (0.49) POLBRAB9ASMN1; SMN2NPC1TP53
SCHEMBL15436746 0.77 CSF1R (0.41) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL15436493 0.77 CSF1R (0.40) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19868327 0.76 CREBBP (0.35) POLBSMN1; SMN2TSHRHTTHPGD
SCHEMBL1863248 0.76 PIN1 (0.39) LMNA
SCHEMBL15436762 0.73 CSF1R (0.41) POLBRAB9ASMN1; SMN2NPC1TP53
SCHEMBL25293709 0.70 HPSE (0.36) POLBRAB9ASMN1; SMN2NPC1TP53
SCHEMBL9980598 0.70 CNR1 (0.49) POLBRAB9ASMN1; SMN2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215079-B1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2016-12-14 EP disclosed
EP-2687516-A1 Inhibitors of C-FMS Kinase Janssen Pharmaceutica N.V. (BE) 2014-01-22 EP disclosed